On June 23, BridgeBio Pharma rose 5.04% in regular trading, trading at $69.625/share, with Turnover of $67.435 million.
Within the Biotechnology sector where BridgeBio Pharma belongs, individual stock performance was mixed. Among individual stocks, Apogee Therapeutics up 46.71%, AbbVie up 6.95%, Gilead Sciences up 0.97%, Regeneron Pharmaceuticals down 0.18%, Moderna down 5.8%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)